Company Monitoring Page for EXACT-Sciences

latest headlines for company on cafepharma

Exact Sciences Acquires 2 Cancer Diagnostic Companies
Motley Fool
Wed, 03/4/20 - 12:05 am
Tags:
EXACT Sciences, M&A, diagnostics, cancer, Paradigm Diagnostics, Viomics
Exact Sciences Should Benefit from Pfizer’s News Today
Motley Fool
Thu, 12/19/19 - 12:05 am
Tags:
Pfizer, colorectal cancer, EXACT Sciences, FDA, Braftovi, Cologuard
The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings
Yahoo/Benzinga
Sun, 10/27/19 - 10:55 pm
Tags:
Adamis Pharmaceuticals, Redhill Biopharma, Amag Pharmaceuticals, Arqule, Agile Therapeutics, Agios Pharmaceuticals, Deciphera, Mirati Therapeutics, Sutro BioPharma, Merck, Pfizer, Amgen, EXACT Sciences, Bristol-Myers Squibb, Celgene, Oyster Point Pharma
Exact Sciences Gets FDA Nod for Label Expansion of Cologuard
Yahoo/Zacks.com
Wed, 09/25/19 - 09:10 am
Tags:
EXACT Sciences, Cologuard, diagnostics, colorectal cancer
How $2.8B Genomic Health deal catapults Exact beyond Cologuard
BioCentury
Mon, 07/29/19 - 11:21 pm
Tags:
EXACT Sciences, M&A, Genomic Health, Cologuard, cancer, diagnostics
Exact Sciences Buying Genomic Health in $2.8B Cancer Diagnostics Deal
Xconomy
Mon, 07/29/19 - 09:28 am
Tags:
EXACT Sciences, M&A, Genomic Health, diagostics
How Exact Sciences Reinvented Itself
Medical Devices and Diagnostics Industry
Mon, 05/27/19 - 11:48 pm
Tags:
diagnostics, EXACT Sciences, Kevin Conroy
Why Exact Sciences Stock Sank Today
Motley Fool
Wed, 03/27/19 - 11:31 pm
Tags:
EXACT Sciences, Affordable Care Act, Cologuard
As Exact Sciences’ Sales Surge, CEO Reflects on 10-Year Turnaround
Xconomy
Wed, 03/20/19 - 08:18 pm
Tags:
EXACT Sciences, Kevin Conroy, diagnostics, colorectal cancer, Cologuard
Exact Sciences Hit a Home Run in Q4. Here's Why Sales Could Soon Soar Even More
Yahoo/Motley Fool
Sun, 02/24/19 - 11:22 pm
Tags:
EXACT Sciences, earnings, Cologuard
4 Things Exact Sciences Investors Should Know About 23andMe's New Cancer Test
Motley Fool
Tue, 01/29/19 - 12:01 pm
Tags:
23andMe, EXACT Sciences, diagnostics, colorectal cancer, Cologuard
Behind the Exact Sciences/Pfizer Cologuard co-promotion deal
Medical Marketing and Media
Fri, 08/24/18 - 11:05 am
Tags:
Pfizer, EXACT Sciences, Cologuard, diagnostics, colon cancer
Exact Sciences signs marketing deal with Pfizer for cancer test
Yahoo/Reuters
Wed, 08/22/18 - 10:02 am
Tags:
Pfizer, EXACT Sciences, Cologuard, diagnostics, colon cancer
Exact Sciences Misses Revenue Estimates by $1.8 Million -- But It Cost the Company a Lot More
Motley Fool
Thu, 08/2/18 - 10:12 am
Tags:
EXACT Sciences, earnings
Why Exact Sciences Shares Are Rallying 13.8% in 2018
Motley Fool
Sun, 07/8/18 - 11:08 am
Tags:
EXACT Sciences, colon cancer, American Cancer Society, Cologuard
20 Million More Potential Customers for Cologuard
Motley Fool
Mon, 06/4/18 - 09:40 am
Tags:
EXACT Sciences, colorectal cancer, Cologuard, diagnostics
Exact Sciences Needs New Study to Fully Benefit From ACS Change
Xconomy
Thu, 05/31/18 - 08:15 pm
Tags:
EXACT Sciences, colorectal cancer, American Cancer Society, Cologuard
2 Reasons Exact Sciences Investors Shouldn't Worry -- and 1 Reason They Should
Motley Fool
Tue, 02/27/18 - 11:46 am
Tags:
EXACT Sciences, earnings, Cologuard
Exact Sciences: Severe Flu Season Slows Down Cancer Test’s Sales
Xconomy
Mon, 02/26/18 - 10:29 am
Tags:
EXACT Sciences, Cologuard, Flu, diagnostics
The Winners And Losers Of JP Morgan Monday
Forbes
Mon, 01/8/18 - 10:23 pm
Tags:
JPMHC 2018, Cellular Biomedicine, Alder Biopharmaceuticals, Nevro, Insulet, PTC Therapeutics, Axovant Sciences, Momenta, Natus Medical, Oxford Immunotec, EXACT Sciences

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.